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Abbreviations 
AMPA, α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate 
ARC, Activity- regulated Cytoskeleton-associated protein 
ASD, Autsm Spectrum Disorder 
Brp, Brunchpliot 
DGluRⅡA, Drosophila Glutamate Receptor ⅡA 
DISC1, Disrupted in Schizophrenia 1 
DISC1OE, DISC1 overexpression 
DTNBP1, Dystrobrebin-Binding Protein 1 
dysb, dysbindin 
dfmr1, Drosophila fragile-X mental retardation 1  
FMR1, Fragile-X Mental Retardation 1 
FMRP, Fragile-X Mental Retardation 1 Protein 
KAL7, Kalirin-7 
MACF1, Microtubule-Actin Crosslinking Factor 1 
MAP1B, microtubule-Associated protein 1B 
NMJ, Neuromuscular Junction 
PAK1, P21-activated kinase 1  
PLA, Proximity ligation Assay 
RAC1, Ras-related C3 botulinum toxin substrate 1 
TNIK, Traf2 and Nck-interacting Kinase 
VNC, Ventral nerve cord 
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Abstract 
Dysregulated neurodevelopment with altered synaptic structure and function is believed 
to underlie diverse neuropsychiatric disorders, and the notion that mental disorders are 
diseases of synaptic functions is a major hypothesis for the biological basis of mental 
dysfunctions. Disrupted-in-Schizophrenia-1 (DISC1) has been suggested to be a potent 
susceptibility gene for wide range of mental illnesses. Although recent studies have 
implicated the importance of DISC1 in synapse functions and development, how DISC1 
plays a role in the pathogenesis of mental illness including in conjunction with other 
psychiatric risk genes remains elusive. Here, I investigated the molecular genetic 
functions of DISC1 with the nervous system of the fruit fly, Drosophila melanogaster. 
Overexpression of DISC1 in fly neurons caused suppression of glutamatergic 
synaptogenesis in developing neuromuscular junctions. To further understand the 
molecular mechanism of DISC1 that controls synaptic development and function, I have 
examined genetic interactions between DISC1 and a select set of risk genes for multiple 
psychiatric disorders using the fly glutamatergic synaptogenesis. Systematic genetic 
screen identified several interacting genes including dysbindin and Drosophila fragile-X 
mental retardation 1 (dfmr1), both of which have crucial roles for synaptic development 
and plasticity and genetically modified the DISC1 phenotype in the glutamatergic 
synaptogenesis. Further analyses demonstrated direct protein-protein interaction of the 
DISC1 and the Dysbindin proteins in the developing synapses. I also describe 
alterations of both pre- and postsynaptic alterations of the DISC1 phenotypes by dfmr1 
mutations. These data implicate complex but pivotal roles of DISC1 in the regulations 
of the molecular synaptic signatures that may cause functional abnormalities of the 
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glutamatergic synapses and may at least in part reflect a common molecular etiology for 
diverse psychiatric diseases. 
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Introduction 
Schizophrenia is a debilitating psychiatric disorder that affects about 1% of the 
population worldwide (Weinberger, 2011, Insel, 2010). Although the etiology of 
schizophrenia has remained elusive, recent genome wide and familial lineage studies on 
patients with schizophrenia strongly suggest the presence of multiple genetic risk 
factors underlying the pathology. Indeed, numerous candidates for risk factor loci have 
been reported to date (Schizophrenia Psychiatric Genome-Wide Association Study, 
2011, Ripke et al., 2013, Szatkiewicz et al., 2013, Kirov et al., 2012, Fromer et al., 2014, 
Purcell et al., 2014, Schizophrenia Working Group of the Psychiatric Genomics, 2014). 
One of the most supported hypotheses is that schizophrenia is a neurodevelopmental 
disease caused by disrupted synaptic formation and function (Mirnics et al., 2001, Ross 
et al., 2006, Insel, 2010). Several lines of evidence from recent epidemiological, 
neuroimaging and genetic studies support this hypothesis: (1) in postmortem brain of 
patients in schizophrenia, the density of dendritic spines, where most excitatory 
synapses in the brain are built on, were altered in multiple brain regions (Glausier and 
Lewis, 2013); (2) classical brain imaging techniques and the adaption of algorithms 
from network science revealed alterations in functional brain network connectivity 
between brain regions associated with higher cognitive functions such as prefrontal 
cortex, thalamus and hippocampus (Pratt et al., 2012); (3) a large number of risk genes 
for schizophrenia encode genes for synaptic proteins, which function in the pathways 
regulating synaptic development and plasticity (Kirov et al., 2012, Fromer et al., 2014); 
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(4) in good agreement with the genetic studies, molecular approaches with gene 
expression profiling of schizophrenia have demonstrated alterations in a group of 
transcripts encoding proteins that regulate synaptic functions (English et al., 2011, 
Horvath et al., 2011, Mirnics et al., 2006). 
It is notable that dendritic spine pathology and altered functional brain 
dysconnectivity have also been observed in other neuropsychiatric disorders such as 
bipolar disorder, autism spectrum disorder (ASD) and Alzheimer’s disease (Konopaske 
et al., 2014, Penzes et al., 2011, Diwadkar et al., 2014, Tao et al., 2013, Voineagu and 
Eapen, 2013, Minshew and Keller, 2010). On the other hands, genetic studies in diverse 
psychiatric disorders have suggested that many of the genetic risk loci found with 
schizophrenia are shared with other psychiatric diseases (Purcell et al., 2014, McCarthy 
et al., 2014, Kenny et al., 2014, Rauch et al., 2012, Pinto et al., 2010). It is also notable 
that a large number of such common risk loci encode genes for synaptic proteins, 
suggesting convergence in their biological functions to the pathways regulating synaptic 
development and plasticity (Ebert and Greenberg, 2013, Delorme et al., 2013, Hall et al., 
2015, Schizophrenia Working Group of the Psychiatric Genomics, 2014, Kirov et al., 
2012, Fromer et al., 2014), rendering further support to the synaptic hypothesis that 
disrupted neuronal connectivity and signaling might be one of the pivotal causes for 
brain dysfunctions in patients with diverse psychiatric diseases (Moghaddam and Javitt, 
2012, Insel, 2010, Weinberger, 2011). 
DISC1 was originally identified in a large Scottish family with a wide range 
of mental disorders including schizophrenia, major depression, bipolar disorder and 
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autism spectrum disorder (Soares et al., 2011, Porteous et al., 2011, Narayan et al., 2013, 
Hikida et al., 2012, Brandon and Sawa, 2011, Bradshaw and Porteous, 2012). Biological 
evidence has accumulated that DISC1 encodes a multifunctional protein important for 
brain development and physiology. In particular, recent biochemical and animal model 
studies have suggested the important role of DISC1 in synaptic development and 
plasticity (Wang et al., 2011, Hayashi-Takagi et al., 2010, Camargo et al., 2007). 
Nevertheless, except for the unique Scottish pedigree, how the DISC1 locus is 
implicated at the genetic level in major mental disorders is still elusive with little 
success in genome-wide association studies to identify the locus as a prominent hit for 
schizophrenia (Kirov et al., 2012, Szatkiewicz et al., 2013). This enigma in turn might 
imply an intricate underlying mechanism that involves complex genetic interactions 
with other loci that exert functional modifications of neuronal DISC1 functions in the 
brain. 
To further understand the molecular network of DISC1 on synapse, 
genetically tractable model animals are challenging but necessary. The fruit fly 
(Drosophila melanogaster) has been used as a powerful model for understanding 
cellular and molecular mechanisms of diverse neurological disorders (Wangler et al., 
2015, Lessing and Bonini, 2009, Bellen et al., 2010). In conjunction with the 
commonality of molecular genetic mechanisms in brain development (Wangler et al., 
2015, Lessing and Bonini, 2009, Bellen et al., 2010), the vast array of transgenic 
techniques in fruit flies allows us to study human neurological disease genes either by 
loss-of-function or by gain-of-function approaches, involving overexpression of human 
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disease genes in the fly brain. Whereas phenocopying human psychiatric symptoms is a 
major challenge for animal models, particularly in evolutionary distant species such as 
fruit flies, recent efforts toward a framework for basic research on mental disorders 
highlight the importance of elucidating the underlying mechanisms of mental 
dysfunction (Morris and Cuthbert, 2012, Insel et al., 2010, Cuthbert, 2014). In such a 
framework, mental disorders can be addressed as disorders of brain circuits, which can 
be studied at multiple biological and genetic levels using non-human models. In line 
with this concept, several studies have utilized the fly model in the past few years to 
reveal the underlying mechanisms of diverse mental disorders at the molecular and 
genetic levels (van der Voet et al., 2014, van Alphen and van Swinderen, 2013, 
Sawamura et al., 2008, Furukubo-Tokunaga, 2009, Doll and Broadie, 2014, 
Androschuk et al., 2015). Although the DISC1 gene is not conserved in the fly genome 
(Bord et al., 2006), fruit flies exhibit significant conservation (92%) of the genes that 
encode the DISC1 interacting proteins (Camargo et al., 2007) (Table 1), providing a 
platform for molecular genetic analyses of its functions and interactors in 
synaptogenesis.  
The fly larval neuromuscular junction (NMJ) exhibits several important 
features in common with the excitatory synapses in the vertebrate brain (Collins and 
DiAntonio, 2007, Schwarz, 2006, DiAntonio, 2006, Menon et al., 2013, Charng et al., 
2014). The fly NMJ utilizes glutamate as the major transmitter, and ionotrophic 
glutamate receptors that are homologous to human receptors are expresses at the NMJ 
(Schwarz, 2006, DiAntonio, 2006, Collins and DiAntonio, 2007). In addition, as with 
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the vertebrate central synapse, the synapses on the fruit fly NMJ exhibit dynamic 
plasticity with organized series of boutons that are formed auxiliary or eliminated 
during development and plasticity (Menon et al., 2013, Collins and DiAntonio, 2007, 
Charng et al., 2014). The fact that the fruit fly NMJ shows stereotypic synaptic 
connections with unique and identifiable presynaptic motoneurons and postsynaptic 
muscles make the system highly useful for studying the molecular genetic mechanisms 
of synaptogenesis and functions (Menon et al., 2013, Koles and Budnik, 2012, Collins 
and DiAntonio, 2007, Bayat et al., 2011).  
In this study, as a way to analyze interactions between DISC1 and diverse 
psychiatric risk factor genes involved in pathological processes, I expressed the human 
DISC1 gene in the fly NMJ and investigated the molecular machinery of DISC1 and the 
genetic interactors that controls glutamatergic synaptogenesis. Overexpression of 
DISC1 (DISC1OE) in fly neurons caused suppression of glutamatergic synaptogenesis in 
developing neuromuscular junctions. To further understand the molecular mechanism of 
DISC1 that controls synaptic development and function, I have examined genetic 
interactions between DISC1 and a select set of risk genes for multiple psychiatric 
disorders using the fly glutamatergic synaptogenesis. Systematic genetic screen 
identified several interacting genes including dysbindin (dysb) and Drosophila fragile-X 
mental retardation 1 (dfmr1), both of which have crucial roles for synaptic development 
and plasticity and genetically modified the DISC1 phenotype in the glutamatergic 
synaptogenesis. Further analyses demonstrated direct protein-protein interaction of the 
DISC1 and the Dysbindin proteins in the developing synapses. I will also describe 
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alterations of both pre- and postsynaptic alterations of the DISC1 phenotypes by dfmr1 
mutations. These data implicate complex but pivotal roles of DISC1 in the regulations 
of the molecular synaptic signatures that may cause functional abnormalities of the 
glutamatergic synapses and may at least in part reflect a common molecular etiology for 
diverse psychiatric diseases. 
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Results 
Overexpression of DISC1 suppresses synaptic development in fruit fly NMJ  
To investigate molecular function of DISC1 in synapse development, I performed 
anatomical analysis of developing NMJ overexpressing DISC1. I found that 
overexpression of DISC1 (DISC1OE) with a ubiquitous driver (tubP-GAL) caused mild 
but significant reduction in the total synaptic bouton area although the numbers of 
synaptic boutons and axonal branch points were not altered (Fig. 1).  
 
Genetic screen of DISC1 interactors in fruit fly synaptogenesis 
To identify genetic factors that modify DISC1OE phenotype in glutamatergic 
synaptogenesis, I set up a genetic crossing (Fig. 2) between the DISC1OE flies and the fly 
mutants of diverse psychiatric risk genes. The mutations used in this study range from 
null to hypomorphic mutants, which could lead to ~50% reduction at most in the gene 
dosage under the heterozygous condition used in this screen, and only partially affect 
synaptic formations on their own. To evaluate genetic modifications, I compared NMJ 
synaptic anatomy with that of the phenotype caused by DISC1OE alone, focusing on the 
three morphological parameters (bouton area, number of boutons, and number of axonal 
branch points), and compared them with the phenotype caused by DISC1OE alone. I 
examined mutations found on the fly autosomes (second and third chromosomes) using 
the genetical scheme. Despite the small number of mutations analyzed, I found several 
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genes, including dysbindin (dysb) and dfmr1, the fruit fly homolog of the human 
DTNBP1 and FMR1 gene, respectively (Kurita et al., in preparation).  
 
DISC1 directly interacts with Dysbindin in glutamatergic synaptogenesis 
Recent protein–protein interaction (PPI) analysis of DISC1 suggested that DTNBP1 and 
DISC1 might share common protein interactions and affect common biological 
processes (Camargo et al., 2007). In addition, previous in vitro assay implicated direct 
interaction between DISC1 and DTNBT1 (Ottis et al., 2011). Because of this 
importance, among the candidate genes identified, firstly I focused on dysbindin (dysb), 
the fruit fly homolog of the human DTNBP1 gene. Mutation of dysb caused intriguing 
enhancement of the DISC1 phenotype (Fig. 3). DISC1 suppressed the synaptic area 
more profoundly in dysbe01028/+ heterozygous background (Fig. 3C). Moreover, DISC1 
caused significant reductions in the number of boutons and the individual bouton size in 
the dysbe01028/+ heterozygous background (Fig. 3D and 3F). On the other hand, the 
number of axonal branch points of the motor neurons was not changed, arguing for 
specific suppression of synaptic bouton formation (Fig. 3E). 
In order to determine whether DISC1 directly interacts with the fruit fly 
Dysbindin in synaptogenesis, we applied the proximity ligation assay (PLA) technique 
(Wang et al., 2015, Soderberg et al., 2006) in the larval NMJs. In this assay, the target 
proteins are localized with specific primary antibodies, which are then detected with 
secondary antibodies conjugated to PLA-PLUS or MINUS oligonucleotide probes. The 
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attached probes can be bridged through hybridization of connector oligonucleotides 
only when the two proteins are in close proximity to make direct contact. The annealed 
oligonucleotides are then closed by ligation into circular DNA molecules, which serve 
as templates for subsequent rolling circle amplification to be visualized by in situ 
hybridization with a fluorescently labeled probe. In negative control, I detected a few 
punctate PLA signals at the larval NMJ, which might be background signals due to 
non-specific binding of primary or secondary antibodies (Fig. 4A and 4B). On the other 
hand, prominent PLA signals were present at NMJ co-expressing both UAS-DISC1 and 
UAS-Venus::Drosophila Dysbindin (Fig. 4C and 4D). Furthermore, statistical analysis 
suggested that PLA signals at NMJ co-expressing both UAS-DISC1 and 
UAS-Venus::Drosophila Dysbindin were significantly higher than those at negative 
control NMJs (Fig. 4E). These results as a whole suggest an intriguing functional 
interaction between DISC1 and Dysbindin in the development of glutamatergic 
synapses. 
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Discussion 
Synaptic development and plasticity have been hypothesized as crucial mechanisms of 
diverse mental disorders (Kirov et al., 2012, Purcell et al., 2014, Ebert and Greenberg, 
2013, Delorme et al., 2013). In particular, it has been hypothesized that altered 
glutamate neurotransmission might be a critical cause for cognitive deficits in 
schizophrenia and other mental disorders (Kantrowitz and Javitt, 2012, Laruelle, 2014). 
Recent molecular studies have demonstrated the importance of DISC1 for synaptic 
development and plasticity (Hikida et al., 2012, Porteous et al., 2011, Bradshaw and 
Porteous, 2012, Narayan et al., 2013, Soares et al., 2011, Brandon and Sawa, 2011, 
Camargo et al., 2007, Hayashi-Takagi et al., 2010, Wang et al., 2011). In this study, I 
expressed human DISC1 in developing fly glutamatergic NMJ and found that DISC1OE 
causes mild but significant suppression in the total synaptic area. In addition, the 
Drosophila homolog of DTNBP1 (dysbindin) and FMR1 (dfmr1) exhibited functional 
interactions with DISC1 in glutamatergic synaptogenesis. Furthermore, I found that 
DISC1 functionally interacts with dysbindin in synaptic development via direct protein– 
protein interaction, and that mutations of dfmr1 modify the DISC1OE synaptic 
phenotypes at the morphological and molecular levels.  
 
Overlapping regulatory networks of DISC1 and Dysbindin in synaptic 
development 
In this study, I have shown that DISC1 interacts with dysbindin in synaptic development. 
Initially found as a component of the dystrophin–dystroglycan complex (Benson et al., 
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2001), Dysbindin was subsequently identified as a component of biogenesis of 
lysosome-related organelles complex that controls organelle biogenesis and intracellular 
membrane trafficking (Ghiani et al., 2010, Iizuka et al., 2007). Dysbindin is expressed 
in both pre- and post-synaptic cells to control dendritic spine formation through the 
association with WAVE-2 and Abi-1, key regulators of Ras-related C3 botulinum toxin 
substrate 1 (Rac1) that control actin cytoskeletal dynamics (Ito et al., 2010). 
Consistently, knockdown of dysbindin results in disorganization of actin cytoskeletons 
that accompanies neurite shortening and growth cone abnormality (Ma et al., 2011, 
Ghiani et al., 2010). Interestingly, it has been shown that Dysbindin controls synaptic 
development and functions in fruit flies (Dickman and Davis, 2009, Shao et al., 2011). 
Studies of DISC1 interactome (Camargo et al., 2007) suggested that 
Dysbindin and DISC1 bind several proteins in common, such as microtubule 
crosslinking factors Dystonin (DST/BPAG1) and microtubule-actin crosslinking factor 
1 (MACF1). Both DISC1 and Dysbindin interact with members of the exocyst complex 
(Camargo et al., 2007), which regulate protein trafficking to synaptic terminals in both 
vertebrates and fruit flies (Heider and Munson, 2012, Mehta et al., 2005, Jafar-Nejad et 
al., 2005). It is also noteworthy that DISC1 interacts directly with Traf2 and 
Nck-interacting kinase (TNIK), a psychiatric risk factor and an activator of Wnt target 
genes (Wang et al., 2011), which in turn interacts with DST (Camargo et al., 2007). 
Moreover, the fly homolog (short stop) of MACF1 and DST has critical roles in axonal, 
dendritic and synaptic development (Lee et al., 2007, Alves-Silva et al., 2012). These 
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lines of evidence suggest a converging mechanism of FMRP and DISC1 in the 
cytoskeletal regulation in the developing synapses. 
Recently, Ottis et al. (Ottis et al., 2011) have suggested intriguing 
convergence of DISC1 and Dysbindin by showing that DISC1 recruits Dysbindin into 
protein aggresomes in mouse neuroblastoma cells via protein–protein interaction 
mediated by the amino acids 316–597, which is consistent with the domains involved 
for synaptic modulation in fruit fly NMJs. Physical interaction between Dysbindin and 
DISC1 is also critical for the stability of Dysbindin and for neurite out growth in 
cultured neuronal cells (Lee et al., 2015). Taken together, our results as a whole suggest 
a complex but intriguing converging mechanism controlled by DISC1 and Dysbindin in 
the developing glutamatergic synapses.  
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Conclusions 
In this study, I have performed molecular genetic dissections of the DISC1 functions in 
the development of the fruit fly glutamatergic synapses. It is noteworthy that the 
behavioral and developmental alterations caused by the overexpression of DISC1 in the 
fruit fly cognitive centers correspond to the endophenotypes that have been observed in 
murine models and human patients. This cross-species compatibility is likely mediated 
by the interactions between the human DISC1 and the associating fly proteins that are 
conserved despite the evolutionary distance. Genetic studies addressing epistatic 
mechanisms in mental disorders are so far limited but warranted to understand the 
molecular mechanisms that may involve complex polygene interactions of diverse 
psychiatric risk factor genes. In this perspective, my study would provide a foundation 
for further studies on the molecular genetic mechanisms of DISC1 functions using fruit 
flies. Given the unparalleled power of the Drosophila genetics, it is feasible to 
systematically identify interacting genetic loci that collaboratively function in vivo 
through shared pathways. Combined with the recent advancement in human psychiatric 
genetics, the fruit fly provides insights relevant to the understanding of the etiology of 
mental disorders at the brain circuit level. 
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Materials and Methods 
Fly stocks 
A white (w) stock outcrossed with Canton S 10 times (w (CS10)) was used as the 
standard stock. Construction of transgenic flies carrying UAS-DISC1 transgene has been 
described previously (Furukubo-Tokunaga et al., 2016, Sawamura et al., 2008). To 
ensure homogeneous genetic background, fly stocks were outcrossed to w (CS10) at 
least 5 times. The tubP-GAL4 (O'Donnell et al., 1994) was obtained from the 
Bloomington Stock Center (Bloomington, IN, USA). All stocks were raised at 25 ˚C on 
a standard food consisting of 5.5 g/L agar, 40 g/L yeast extract, 90 g/L cornmeal, 100 
g/L glucose. Propionic acid (3 ml/L) and n-butyl-p-hydroxybenzoate (0.7 g/L) were 
added as fungicides. 
Immunohistochemistry  
Immunological staining was performed as described previously (Kurusu et al., 2002). 
The following antibodies were used: sheep anti-DISC1 antibody diluted 1:50 (AF6699, 
R&D systems, Minneapolis, MN, USA), mouse anti-Synaptotagmin diluted 1:2 (3H2 
2D7, Developmental Studies Hybridoma Bank (DSHB), University of Iowa, IA, USA) 
(Dubuque et al., 2001), anti-Horseradish peroxidase protein (HRP) conjugated with 
fluorescein-isothiocyanate diluted 1:100 (Jackson ImmunoResearch, West Grove, PA, 
USA), and Alexa-conjugated secondary antibodies diluted 1:200 (Molecular probes, 
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Eugene, OR, USA). Confocal images were captured with a Zeiss LSM510 or LSM710 
microscope. 
Genetic screen 
For the screen, mutant lines were balanced with a double balancer stock (w/w; Sp / CyO, 
Act-GFP; Pr Dr/ TM6B, ubi-GFP). The resulting progeny carrying a mutation were 
then crossed either with control (w; +; tubP-GAL4/TM6B, ubi-GFP) or with DISC1OE 
(w; UAS- DISC1(CS10)6-6(II); tubP-GAL4/ TM6B, ubi-GFP) flies. Larvae were raised 
at 25 ̊C, and non-GFP animals were selected for dissection at 116-120 hours after egg 
collection.  
Proximity Ligation Assay 
To examine whether two proteins are in close proximity to make direct contact at the 
larval NMJ, UAS-Venus::Drosophila-Dysbindin (gift from Graeme Davis) (Dickman 
and Davis, 2009) and UAS-DISC1 were co-expressed with tubP-GAL4. Proximity 
ligation assay (PLA) was performed as described previously (Wang et al., 2015). Briefly, 
NMJ of third instar larvae were dissected in ice-cold phosphate saline, fixed for 30 min 
with 4% paraformaldehyde, and incubated with 1% bovine serum albumin in PBT 
(phosphate buffered saline containing 0.1 % Triton X-100). Tissues were then incubated 
with 1:50 dilution of sheep anti-DISC1 (AF6699) and 1:500 dilution of rabbit anti-GFP 
(Molecular Probes, Eugene, OR) overnight at 4˚C. After washing with PBT, tissues 
were further incubated with anti-Horseradish peroxidase (HRP) conjugated with FITC 
for three hours. After washing with PBT, tissues were incubated with 1:15 dilution of 
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anti-rabbit PLUS (DUO092002, Sigma-Aldrich, St. Louis, MO) and anti-goat MINUS 
(DUO092006, Sigma-Aldrich, St. Louis, MO) PLA probes for two hours at 37˚C. After 
washing with wash buffer A  (Duolink, Sigma-Aldrich, St. Louis, MO), ligation 
reaction was done for one hour at 37 ˚C followed by amplification for two hours at 37˚C. 
Tissues were then washed with wash buffer B (Duolink, Sigma-Aldrich, St. Louis, MO) 
and mounted on a slide. PLA signals were captured with confocal microscopy LSM510 
or LSM700 and analyzed with Image J. 
Quantification of NMJ structure and fluorescent intensity 
For quantification of synaptic phenotypes, I used the larval longitudinal muscles 6/7 in 
the abdominal hemisegment A2. Anti-HRP and anti-Synaptotagmin were used to label 
neuronal terminal and synaptic boutons, respectively. Total bouton area was determined 
using Image-J (Schneider et al., 2012) based on anti-Synaptotagmin immunoreactivity. 
Protein expression levels were determined based on fluorescent intensities of the NMJ 
preparations using the control and test samples processed simultaneously in the same 
tube. Confocal images were captured using identical settings. Anti-HRP 
immuno-reactivity was used as an internal control.  
Statistics 
Statistical analysis was performed using GraphPad Prism (GraphPad Software, San 
Diego, CA). Experimental data of anatomical alterations, protein expression and PLA 
signal intensity in NMJ synapses were analyzed using parametric tests (Student’s t-test 
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and one-way ANOVA) without randomization and blinding. For multiple comparisons 
among relevant groups, Dunnett’s post hoc test was used in conjunction with one-way 
ANOVA. Significance levels in the figures are represented as P < 0.05 (*), P < 0.01 
(**) and P < 0.001 (***) by Student’s t-test or one-way ANOVA. Error bars represent 
standard errors of means. 
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Table 1. Drosophila homologues of DISC1 interacting protein 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FL N TR
GNB1 4396 P62873 Guanine nucleotide-binding proteinG(I)/G(S)/G(T) subunit beta-1 - + - G protein β-subunit 13F
KIAA0470 28920 Q5SW79 Centrosomal protein of 170 kDa + + - Mucin 68D
KIFAP3 17060 Q92845 Kinesin-associated protein 3 - + - Kinesin associatedprotein 3
MGC45441 28688 Q8N4L8 Coiled-coil domain-containing protein 24 - - + Cytoplasmic linkerprotein 190
MACF1 13664 Q9UPN3 Microtubule-actin cross-linking factor 1,isoforms 1/2/3/5 + + + short stop
PDE4B 8781 Q07343 cAMP-specific 3',5'-cyclic phosphodiesterase4B + - - dunce
C2orf4 14014 Q9Y316 Protein MEMO1 - + - CG8031
DCTN1 2711 Q14203 Dynactin subunit 1 - - + Glued
FBXO41 29409 Q8TF61 F-box only protein 41 + - - CG9003
IMMT 6047 Q16891 Mitochondrial inner membrane protein - + + CG6455
KIAA1212 25523 Q3V6T2 Girdin + + - Girdin
KIF3C 6321 O14782 Kinesin-like protein KIF3C - + + Kinesin-like protein at68D
MYT1L 7623 Q9UL68 Myelin transcription factor 1-like protein + - - CG43689
SPTBN1 11275 Q01082 Spectrin beta chain, non-erythrocytic 1 + + + β Spectrin
TRAF3IP1 17861 Q8TDR0 TRAF3-interacting protein 1 + + + CG3259
YWHAQ 12854 P27348 14-3-3 protein theta - - + 14-3-3ζ
ARIH2 690 O95376 E3 ubiquitin-protein ligase ARIH2 - + - ariadne 2
FLJ13386 25815 Q96MT8 Centrosomal protein of 63 kDa + - - zipper, sti
KALRN 4814 O60229 Kalirin - - + trio
SH3BP5 10827 O60239 SH3 domain-binding protein 5 + + - parcas
SRGAP2 19751 O75044 SLIT-ROBO Rho GTPase-activating protein 2 - - + -
TNIK 30765 Q9UKE5 TRAF2 and NCK-interacting protein kinase + + - misshapen
ZNF197 12988 O14709 Zinc finger protein 197 - + - crooked legs
KIAA0826 29127 O94915 Protein furry homolog-like + + - furry
SEC3L1 30380 Q9NV70 Exocyst complex component 1 + - + Sec3 ortholog
SPARCL1 11220 Q14515 SPARC-like protein 1 - - + BM-40-SPARC
STX18 15942 Q9P2W9 Syntaxin-18 - - + Syntaxin 18
DPYSL3 3015 Q14195 Dihydropyrimidinase-related protein 3 - + - Collapsin ResponseMediator Protein
KIF3A Q9Y496 Kinesin-like protein KIF3A - + + Kinesin-like protein at64D
MATR3 6912 P43243 Matrin-3 - + - Sh3β
TRIO 12303 O75962 Triple functional domain protein + + + trio
C6orf182 21561 Q8IYX8 Centrosomal protein CEP57L1 - - + CENP-meta, rudhira
CDC5L 1743 Q99459 Cell division cycle 5-like protein + + - Cell division cycle 5ortholog
DST 1090 Q03001 Dystonin + + + short stop
TIAM2 11806 Q8IVF5 T-lymphoma invasion and metastasis-inducing protein 2 - + - still life
TUBB 20778 P07437 Tubulin beta chain - + - betaTub85D
UTRN 12635 P46939 Utrophin - - + Dystrophin
AKAP9 379 Q99996 A-kinase anchor protein 9 + + - Stretchin-Mlck
DKFZP434G156 22225 Q96JN2 Coiled-coil domain-containing protein 136 - - + Cytoplasmic linkerprotein 190
CLU 2095 P10909 Clusterin + + + -
DPYSL2 3014 Q16555 Dihydropyrimidinase-related protein 2 - + - Collapsin ResponseMediator Protein
EIF3S3 3273 O15372 Eukaryotic translation initiation factor 3subunit H + + -
Eukaryotic initiation
factor 3 p40 subunit
RAD21 9811 O60216 Double-strand-break repair protein rad21homolog + + - verthandi
TNKS 11941 O95271 Tankyrase-1 - + - tankyrase
YWHAZ 12855 P63104 14-3-3 protein zeta/delta - - + 14-3-3ζ
Table 1.   Drosophila Homologs of DISC1 Interacting Proteins
UniProt
KB Dorosophila Homologues
1
2
3
4
chomosome Interactors
Physical Interaction
with DISC1Encoded ProteinHGNC
5
6
7
8
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Abbereviations; FL Full length, N N-terminus Region, TR Truncated form 
HGNC : HUGO Gene Nomenclature Committee 
UniProtKB : UniProt Protein knowledgebase 
 
Interacting proteins and the DISC1 domains are according to Camargo et al., 2007.  
Note that 92% (75/82) of the genes encoding the DISC1 interacting proteins have 
homologs in the fly genome. 
 
 
AGTPBP1 17258 Q9UPW5 Cytosolic carboxypeptidase 1 - + - Drosophila Nna1 ortholog
OLFM1 17187 Q99784 Noelin + + - CG6867
RABGAP1 17155 Q9Y3P9 Rab GTPase-activating protein 1 - + -
GTPase activating protein
and centrosome-
associated ortholog
SMC2L1 14011 O95347 Structural maintenance of chromosomesprotein 2 - - + SMC2
SPTAN1 11273 Q13813 Spectrin alpha chain, non-erythrocytic 1 - + - α Spectrin
TUBB2 12412 Q13885 Tubulin beta-2A chain - + - betaTub85D
XPNPEP1 12822 Q9NQW7 Xaa-Pro aminopeptidase 1 + + - Aminopeptidase P
ZNF365 18194 Q70YC5 Protein ZNF365 + - - -
11 NUP160 18017 Q12769 Nuclear pore complex protein Nup160 - + + Nucleoporin 160kD
BICD1 1049 Q96G01 Protein bicaudal D homolog 1 - + - Bicaudal D
DCTN2 2712 Q13561 Dynactin subunit 2 + - + Dynamitin
MGC4170 29670 Q3T906 N-acetylglucosamine-1-phosphotransferasesubunits alpha/beta - - + CG8027
13 - - - - - - - -
C14orf135 20349 Q63HM2 Pecanex-like protein 4 - + - pecanex
C14orf166 23169 Q9Y224 UPF0568 protein C14orf166 - - + CG31249
DNCH1 2961 Q14204 Cytoplasmic dynein 1 heavy chain 1 - + + Dynein heavy chain 64C
SNX6 14970 Q9UNH7 Sorting nexin-6 + - - Sorting nexin 6
15 MN7 4870 - hect domain and RLD 2 pseudogene 2 + - - -
16 FLJ22386 29478 Q9GZN7 Protein rogdi homolog + - - rogdi
ACTG1 144 P63261 Actin, cytoplasmic 2 - + - Actin 5C, Actin 42A
CDK5RAP3 18673 Q96JB5 CDK5 regulatory subunit-associated protein 3 + + - CG30291
DNAJC7 12392 Q99615 DnaJ homolog subfamily C member 7 - + + Tetratricopeptide repeatprotein 2
EXOC7 23214 Q9UPT5 Exocyst complex component 7 + - - Exo70 ortholog
NDEL1 17620 Q9GZM8 Nuclear distribution protein nudE-like 1 + + - nudE
PAFAH1B1 8574 P43034 Platelet-activating factor acetylhydrolase IBsubunit alpha + + - Lissencephaly-1
PPM1E 19322 Q8WY54 Protein phosphatase 1E - + - CG10376
PPP4R1 9320 Q8TF05 Serine/threonine-protein phosphatase 4regulatory subunit 1 - + - -
SMARCE1 11109 Q969G3
SWI/SNF-related matrix-associated actin-
dependent regulator of chromatin subfamily
E member 1
+ - - dalao
YWHAE 12851 P62258 14-3-3 protein epsilon - + + 14-3-3ε
18 - - - - - - - -
EEF2 3214 P13639 Elongation factor 2 - + - Elongation factor 2
PPP5C 9322 P53041 Serine/threonine-protein phosphatase 5 - - + Protein phosphatase D3
CRNKL1 15762 Q9BZJ0 Crooked neck-like protein 1 - + - crooked neck
XRN2 12836 Q9H0D6 5'-3' exoribonuclease 2 - + - Rat1
21 - - - - - - - -
C22orf1 1306 O15442 Metallophosphoesterase domain-containingprotein 1 - + - CG16717
TFIP11 17165 Q9UBB9 Tuftelin-interacting protein 11 - + + septin interacting protein 1
DMD 2928 P11532 Dystrophin + - - Dystrophin
GPRASP2 25169 Q96D09 G-protein coupled receptor-associated sortingprotein 2 - + -
CG3108
nahoda
PGK1 8896 P00558 Phosphoglycerate kinase 1 + - - Phosphoglycerate kinase
Y - - - - - - - -
Abbereviations; FL Full length, N N-terminus Region, TR Truncated form
10
9
Interacting proteins and the DISC1 domains are according to Camargo et al., 2007. Note that 92% (75/82) of the genes encoding the DISC1
interacting proteins have homologs in the fly genome.
X
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Figure 1. Ubiquitous DISC1OE in the fruit fly larval NMJ. 
(A, B) Confocal images of third instar larval NMJs. (A) Control without UAS-DISC1. 
(B) DISC1OE with tubP-GAL4.  (C-E) Quantification of the NMJ morphology with (+) 
or without (-) ubiquitous DISC1OE. (C) Total synaptic bouton area. (D) Number of 
synaptic boutons. (E) Number of axonal branch points. * P < 0.05 with Student’s t-test. 
n.s., not significant. n = 11-15. NMJs of the muscle 6-7 in the second abdominal 
segment were stained with anti-HRP (green) and anti-Synaptotagmin (Syt) (magenta). 
NMJ, neuromuscular junction; DISC1OE, DISC1 overexpression; HRP, horseradish 
peroxidase. Bar, 20μm. 
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Figure 2. Genetic screen of DISC1 interactors in the fruit fly synaptogenesis. 
Mutant flies (+/CyO-GFP; mutation/TM6B-GFP) of the fruit fly homologue for a 
schizophrenia risk gene are crossed with the control (+/+; tubP-GAL4/TM6B-GFP) or 
the DISC1OE (UAS-DISC1; tubP-GAL4/TM6B-GFP) flies. Larval NMJs of the control 
(+/+; mutation/tubP-GAL4) and DISC1OE (+/UAS-DISC1; mutation/tubP-GAL4) 
progenies were compared. Note that while both progenies are heterozygous for the 
mutation, control flies carry the tubP-GAL4 but not the UAS-DISC1 transgene. 
Illustrated are the genetic crossings for a third chromosome mutation. Similar crossings 
were performed for second chromosome mutations. DISC1OE, DISC1 overexpression. 
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Figure 3. DISC1 genetically interacts with dysbindin in the development of 
glutamatergic synapses.  
(A, A’, A”, B, B’, B”) Synaptic terminal branches of dysbe01028 heterozygous NMJs 
without (A) or with (B) DISC1OE. (A’, B’) Motor neuron termini labeled with an 
anti-HRP (Green in A and B). (A”, B”) Synaptic boutons labeled with 
anti-Synaptotagmin (Magenta in A and B). Scale bar, 40 μm. (C-F) Quantification of 
NMJ synaptogenesis in w (CS10) control and dysbe01028 /+ backgrounds with (+) or 
without (-) ubiquitous DISC1OE. (C) Total synaptic bouton area. (D) Number of synaptic 
boutons. (E) Individual synaptic bouton size. (F) Number of axonal branch points. *P < 
0.05, **P < 0.01 and ***P < 0.001 with Student’s t-test, n = 10 for each genotype. NMJ, 
neuromuscular junction; DISC1OE, DISC1 overexpression; HRP, horseradish 
peroxidase.  
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Figure 4. DISC1 directly interacts with the Drosophila Dysbindin in the larval 
NMJ.  
(A–D) Confocal images of PLA signals in the third inster larval NMJ. (A and B) PLA 
in w (CS10) control NMJs. (C, D) PLA in NMJs expressing Drosophila Dysbindin and 
DISC1. UAS-Venus::Drosophila Dysbindin and UAS-DISC1 were co-expressed with 
tubP-GAL4. (B, D) Higher magnification of the area indicated in (A) and (C). Green, 
motor neuron termini labeled with anti-HRP. Magenta, PLA signals. Scale bars, 10 μm. 
(e). Quantification of PLA signals. Venus::Dysbindin was detected with anti-GFP. *** 
P < 0.001 by one-way ANOVA followed by Dunnett’s post hoc test. n = 9–19. NMJ, 
neuromuscular junction; PLA, proximity ligation assay; GFP, green fluorescent protein.  
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